Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-05-14 pm EDT 5-day change 1st Jan Change
3.85 USD -1.91% Intraday chart for Avinger, Inc. +2.39% +42.07%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 6.23M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.59 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.45 x
P/E ratio 2024 *
-1.89 x
P/E ratio 2025 *
-2.91 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.91%
1 week+2.39%
Current month+2.94%
1 month-10.15%
3 months+30.07%
6 months+11.27%
Current year+42.07%
More quotes
1 week
3.60
Extreme 3.6
4.15
1 month
3.42
Extreme 3.42
4.15
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
1 710.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-05-14 3.85 -1.91% 10,550
24-05-13 3.925 +3.35% 18,257
24-05-10 3.798 -1.50% 6,418
24-05-09 3.856 +0.52% 3,042
24-05-08 3.836 +2.01% 1,002

Delayed Quote Nasdaq, May 14, 2024 at 04:30 pm EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.925 USD
Average target price
5 USD
Spread / Average Target
+27.39%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW